Cargando…
Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation
NSP16 is one of the structural proteins of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) necessary for its entrance to the host cells. It exhibits 2’O-methyl-transferase (2’O-MTase) activity of NSP16 using methyl group from S-adenosyl methionine (SAM) by methylating the 5-end of v...
Autores principales: | Kumar, Subodh, Singh, Harvinder, Prajapat, Manisha, Sarma, Phulen, Bhattacharyya, Anusuya, Kaur, Hardeep, Kaur, Gurjeet, Shekhar, Nishant, Kaushal, Karanveer, Kumari, Kalpna, Bansal, Seema, Mahendiratta, Saniya, Chauhan, Arushi, Singh, Ashutosh, Soloman Singh, Rahul, Sharma, Saurabh, Thota, Prasad, Avti, Pramod, Prakash, Ajay, Kuhad, Anurag, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392196/ https://www.ncbi.nlm.nih.gov/pubmed/37533429 http://dx.doi.org/10.1177/11779322231171777 |
Ejemplares similares
-
Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
por: Kumar, Subodh, et al.
Publicado: (2021) -
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
por: Chauhan, Arushi, et al.
Publicado: (2021) -
In Silico Structure-Based Repositioning of Approved Drugs for Spike Glycoprotein S2 Domain Fusion Peptide of SARS-CoV-2: Rationale from Molecular Dynamics and Binding Free Energy Calculations
por: Shekhar, Nishant, et al.
Publicado: (2020) -
Virtual screening and molecular dynamics simulation study of approved drugs as a binder to the linoleic acid binding site on spike protein of SARS-CoV-2 and double mutant (E484Q and L452R)
por: Prajapat, Manisha, et al.
Publicado: (2022) -
Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review
por: Kaur, Hardeep, et al.
Publicado: (2021)